Search

everythinglearnresearchcommunity

for

Search:↓

Red pigmented rice, like Sang-Yod rice, could help promote hair growth and prevent hair loss.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

Fibroblasts are crucial for tissue repair and inflammation, and understanding them can help treat fibrotic diseases.

Hidradenitis suppurativa is caused by genetic factors, inflammation, bacteria, hormones, and lifestyle factors like obesity and smoking.

Flavonoids in Iraqi marshland plants have potential health benefits like antioxidant and anti-inflammatory effects.

Low-level laser therapy is the most effective for hair loss, but other treatments also show promise.

In June 2019, the stem cell research field saw major progress, including new clinical trials, FDA approvals, and industry collaborations.

Oral tofacitinib significantly improves lichen planopilaris symptoms without adverse effects.

Biotrinine® may be an effective treatment for chronic hair loss.

New treatments are making advanced prostate cancer management more complex but also more hopeful.

Eating high-glycemic and dairy foods can increase hormones that may cause acne and other health issues.

Photodynamic Therapy is an effective treatment for mild to severe acne.

Certain types of T cells are essential for healthy skin and play a role in skin diseases, but more research is needed to improve treatments.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

Finasteride may be linked to Peyronie’s disease, but more research is needed.

Adalimumab significantly improved symptoms and quality of life in two patients with Hidradenitis Suppurativa.

Baricitinib effectively promotes hair regrowth in severe alopecia with minimal side effects.

Some men experience persistent sexual, neurological, and psychological symptoms after stopping finasteride, but evidence of permanent damage is inconclusive.

The FDA rejected a testosterone drug again due to safety concerns.

Biotechnology could lead to new hair growth products.

Synthetic hair implants are dangerous and can cause severe infections.

Public awareness of finasteride's sexual side effects has increased, suggesting healthcare providers should discuss these risks more thoroughly with patients.

Direct-to-consumer teledermatology platforms have financial conflicts of interest and lack proper patient care and follow-up.

The FDA did not approve a testosterone drug because of safety concerns.

Nanotechnology improves hair care products by enhancing ingredient stability, targeting treatment, and reducing side effects, but more research on its toxicity is needed.

Using hair loss drugs finasteride and dutasteride may cause sexual side effects.

AI is effective in diagnosing and treating hair disorders, including detecting hair loss and scalp conditions with high accuracy, but it should supplement, not replace, doctor-patient interactions.

The correction states that the label change for Finasteride was in 2012, leading to more reports of side effects from non-healthcare people.

Most Facebook posts about hair loss treatments are promotional and not medically supported, with better quality information found on YouTube.

Finasteride's effectiveness on the frontal hair loss area is not well-studied or confirmed.